DH Capital Advises Latisys on Sale to Zayo

DH Capital Advises Latisys on Sale to Zayo

NEW YORK, NY and BOULDER, CO — (Marketwired) — 02/25/15 — DH Capital, LLC ("DH Capital"), an investment banking firm serving companies in the Internet Infrastructure, communications, and SaaS sectors, announced today that the company served as financial advisor to Latisys Holdings, LLC ("Latisys") on its sale to Zayo Group, LLC ("Zayo") for a price of $675 million, which was completed earlier in the week. The transaction brings together Zayo–s unique fiber asse

Cell MedX Corp. (CMXC) Announces Results of Preliminary Analysis of Metabolomic Assays in Phase 1 Pilot Clinical Trial

Cell MedX Corp. (CMXC) Announces Results of Preliminary Analysis of Metabolomic Assays in Phase 1 Pilot Clinical Trial

LAS VEGAS, NV — (Marketwired) — 02/25/15 — Cell MedX Corp. (OTCQB: CMXC) (the "Company") is pleased to announce that it has received the first results of the analysis of metabolomic assays taken during the Phase 1 pilot clinical trial.The pilot clinical discovery phase trial in two diabetic subjects was performed in January 2015. Its main objective was to examine the short term metabolic impact of a single treatment with e-balance technology. Additional assays are pending. Analysis

1 12 13 14 15 16 125